Magnesium L-threonate gains EU novel food status with exclusive market rights
A proprietary form of magnesium L-threonate has achieved novel food authorisation from the European Union, marking a significant development in bioavailable magnesium supplementation. North American ingredient supplier AIDP and its licensee ThreoTech have secured exclusive EU marketing rights for five years, establishing new regulatory precedent for proprietary ingredient protection in the novel foods category.